We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

15 hedge funds and large institutions have $9.7M invested in VolitionRx Ltd in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

94% more capital inflows, than outflows

Capital inflows: $149K | Capital outflows: $76.4K

0% more funds holding

Funds holding: 15 → 15 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.41% less ownership

Funds ownership: 13.52% → 13.11% (-0.41%)

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$73.8K
2
B. Riley Wealth Advisors
B. Riley Wealth Advisors
Florida
+$41.4K
3
Lagoda Investment Management
Lagoda Investment Management
New York
+$30.8K
4
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$1.59K
5
BlackRock Fund Advisors
BlackRock Fund Advisors
California
+$621

Top Sellers

Rank Fund Capital Flow
1
Virtu KCG Holdings
Virtu KCG Holdings
New York
-$55K
2
UBS Group
UBS Group
Switzerland
-$14.5K
3
Goldman Sachs
Goldman Sachs
New York
-$6.9K

VNRX Hedge Fund Activity: Q2 2016 in Review

15 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2016, worth a combined $9.7M — down 11% from $10.8M a quarter earlier.

Fund positioning in VNRX was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $73.8K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $55K sold.

  • 15 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $9.7M of VolitionRx Ltd stock for Q2 2016, down 11% quarter-over-quarter.
  • 1 fund opened new VolitionRx Ltd positions in Q2 2016 and 1 closed out, a net change of 0 holders.
  • The largest VolitionRx Ltd buyer in Q2 2016 was Morgan Stanley, an estimated $73.8K added.
  • The largest VolitionRx Ltd seller in Q2 2016 was Virtu KCG Holdings, an estimated $55K sold.

Based on aggregated 13F filings for Q2 2016.